#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Selective polysaccharide antibody deficiency Leiomyosarcoma recurrent Pseudoxanthoma elasticum Autoinflammation with infantile enterocolitis Glioma Leukoencephalopathy Paraneoplastic neurological syndrome Macular telangiectasia Malignant glioma Breast angiosarcoma Human papilloma virus immunisation Anal cancer recurrent Chronic myeloid leukaemia (in remission) Philadelphia positive acute lymphocytic leukaemia Ovarian cancer More trials…

    Learn about Rare Diseases

    Ocular melanoma – Treatment Hereditary angioedema with C1 esterase inhibitor deficiency – Treatment Systemic sclerosis pulmonary – Treatment Richter’s syndrome – Life with Disease Gaucher’s disease type III – Trials in Disease Osteosarcoma – Treatment Malignant fibrous histiocytoma – Diagnostics Gastrointestinal stromal tumour – Basic Information Pemphigoid – Life with Disease Splenic marginal zone lymphoma – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Nafarelin Munc-Cd34 Pevonedistat Lumateperone ATTR-01 Seralutinib Lonapegsomatropin L-LEUCINE Other Immunosuppressants Poa Pratensis Exemestane Io103 Acetate Daplusiran Zalunfiban Gremubamab Xanthum Gum Ro7269162 Art6043 Medroxyprogesterone Acetate Mometasone Furoate Monohydrate More therapies…

    Learn about Your Condition

    Lung adenocarcinoma stage III Polycystic ovarian syndrome Reperfusion injury Tricuspid valve disease Chronic lymphocytic leukaemia Otitis media Myeloid leukaemia Indolent systemic mastocytosis Nephrolithiasis Familial mediterranean fever Thrombosis Autism spectrum disorder Tinnitus Erdheim-Chester disease Encephalitis autoimmune More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Specderm Poznanska Sp. j.

Specderm Poznanska Sp. j.

Ul. Prezydenta Ryszarda Kaczorowskiego 7/u 50, Bialystok, 15-375, Poland

Want to learn more about this study or check if you can participate? Contact us.

  • Phase III randomized trial of elecoglipron to assess safety and weight loss in adults with obesity or overweight, with or without type 2 diabetes

    Recruiting

    3 1
    Investigated Drugs:
    • Azd5004
    Germany Italy Poland Spain

  • A study to evaluate the effect of orforglipron on cardiovascular health in adults with atherosclerotic cardiovascular disease and/or chronic kidney disease

    Recruiting

    3 1
    Investigated Diseases:
    • Chronic kidney disease
    • Arteriosclerosis
    Austria Belgium Bulgaria Czechia Estonia France +10

  • Long-term safety study of deucravacitinib compared to ustekinumab in adults with moderate to severe plaque psoriasis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Psoriasis
    Investigated Drugs:
    • Ustekinumab
    • Deucravacitinib
    Belgium Bulgaria Czechia Denmark France Germany +6

  • A Study Testing How Well Bimekizumab Works and How Safe It Is for Adults with Palmoplantar Pustulosis

    Recruiting

    3 1 1
    Investigated Drugs:
    • Bimekizumab
    Czechia Denmark France Germany Hungary Italy +2

  • Evaluation of CIT-013 at two dose levels compared to placebo for treating moderate to severe Hidradenitis Suppurativa

    Recruiting

    2 1
    Investigated Diseases:
    • Hidradenitis
    Germany The Netherlands Poland Spain

  • Study of deucravacitinib compared to placebo in adolescents aged 12-17 years with moderate to severe plaque psoriasis

    Recruiting

    3 1
    Investigated Drugs:
    • Deucravacitinib
    Belgium Germany Hungary Italy Poland Romania +1

  • Study comparing aciclovir gel and cream effectiveness in treating recurrent cold sores (herpes labialis)

    Recruiting

    3 1 1
    Investigated Diseases:
    • Oral herpes
    Investigated Drugs:
    • Aciclovir
    Poland

  • Effect of elecoglipron plus dapagliflozin on cardiovascular outcomes in adults with heart failure with preserved or mildly reduced ejection fraction (HFpEF/HFmrEF)

    Recruiting

    3 1 1
    Investigated Diseases:
    • Heart failure with preserved ejection fraction
    Investigated Drugs:
    • Azd5004
    • Dapagliflozin
    Austria Bulgaria Czechia France Germany Greece +8

  • ICP-332 for Adults with Prurigo Nodularis

    Recruiting

    2 1
    Austria Belgium France Germany Poland

  • Study on the Effectiveness of JNJ-77242113 and Deucravacitinib for Treating Moderate to Severe Plaque Psoriasis in Adults

    Not yet recruiting

    3 1 1
    Investigated Drugs:
    • Jnj-77242113
    • Deucravacitinib
    France Germany Hungary Italy Poland Spain
1 2 3
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!